Decisional capacity for advanced care directives in Parkinson's disease with cognitive concerns

Parkinsonism and Related Disorders

Volumn 39, Issue , 2017, Pages 77-79

  Abu Snineh, Muneer ^a   Camicioli, Richard ^a   Miyasaki, Janis M ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Advance care directives; Capacity to consent; Cognitive; Cognitive complaints; Executive function; Goals of Care; Parkinson's disease; Physician Orders for Life Sustaining Therapies; POLST

Indexed keywords

ANTIDEPRESSANT AGENT; QUETIAPINE;

AGED; ARTICLE; BRAIN DYSFUNCTION; CLINICAL ARTICLE; DECISION MAKING; DISEASE ASSOCIATION; DISEASE DURATION; DRUG EFFECT; EXECUTIVE FUNCTION; FEMALE; HUMAN; MALE; MENTAL CAPACITY; MINI MENTAL STATE EXAMINATION; MONTREAL COGNITIVE ASSESSMENT; PARKINSON DISEASE; PATIENT CARE; PRIORITY JOURNAL; COGNITIVE DEFECT; COMPLICATION; COMPREHENSION; MENTAL HEALTH; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PHYSIOLOGY;

AGED; COGNITION DISORDERS; COMPREHENSION; DECISION MAKING; EXECUTIVE FUNCTION; FEMALE; HUMANS; MALE; MENTAL STATUS SCHEDULE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE;

EID: 85015800611     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2017.03.006     Document Type: Article

References (12)

1. Goals of Care, Alberta Health Services, http://www.albertahealthservices.ca/info/Page9099.aspx (last accessed 11.01.17).
2. Moelter, S.T., Weintraub, D., Mace, L., Cary, M., Sullo, E., Xie, S.X., Karlawish, J., Research consent capacity varies with executive function and memory in Parkinson's disease. Mov. Disord. 31 (2016), 414–417.
3. Santangelo, G., Vitale, C., Picillo, M., Moccia, M., Cuoco, S., Longo, K., Pezzella, D., di Graize, A., Erro, R., Pellecchia, M.T., Amboni, M., Tojano, L., Barone, P., Mild cognitive impairment in newly diagnosed Parkinson's disease: a longitudinal prospective study. Park. Relat. Disord. 21 (2015), 1219–1226.
4. Ahluwalia, S.C., Levin, J.R., Lorenz, K.A., Gordon, H.S., Missed opportunities for advance care planning communication during outpatient clinic visits. J. Gen. Intern Med. 27:4 (2012), 445–451.
5. Grisso, T., Appelbaum, P.S., Hill-Fotouhi, C., The MacCAT-T: a clinical tool to assess patients’ capacities to make treatment decisions. Psychiatr. Serv. 48 (1997), 1415–1419.
6. Lew, M.F., Slevin, J.T., Kruger, R., Castrillo, J.C.M., Chatamra, K., Dubow, J.S., Robieson, W.Z., Benesh, J.A., Fung, V.S.C., Initiation and dose optimization for levodopa-carbidopa intestinal gel: insights from phase 3 clinical trials. Park. Relat. Disord. 21:7 (2015), 742–748.
7. van Hilten, J.J., van der Zwan, A.D., Zwinderman, A.H., Roos, R.A., Rating impairment and disability in Parkinson's disease: evaluation of the unified Parkinson disease rating scale. Mov. Disord. 9 (1994), 84–88.
8. Chou, K.L., Lenhart, A., Koeppe, R.A., Bohnen, N.I., Abnormal MoCA and normal range MMSE scores in Parkinson disease without dementia: cognitive and neurochemical correlates. Park. Relat. Disord. 20 (2014), 1076–1080.
9. Dymek, M.P., Atchison, P., Harrell, L., Marson, D.C., Competency to consent to medical treatment in cognitively impaired patients with Parkinson's disease. Neurology 56 (2001), 17–24.
10. Griffith, H.R., Dymek, M.P., Atchison, P., Harrell, L., Marson, D.C., Medical decision-making in neurodegenerative disease: mild AD and PD with cognitive impairment. Neurology 65 (2005), 483–485.
11. Martin, R.C., Okonkwo, O.C., Hill, J., Griffith, H.R., Triebel, K., Bartolucci, A., Nicholas, A.P., Watts, R.L., Stover, N., Harrell, L.E., Clark, D., Marson, D.C., Medical decision-making capacity in cognitively impaired Parkinson's disease patients without dementia. Mov. Disord. 23 (2008), 1867–1874.
12. Karlawish, J., Cary, M., Moelter, S.T., Siderowf, A., Sullo, E., Zie, S., Weintraub, D., Cognitive impairment and PD patients’ capacity to consent to research. Neurology 81 (2013), 801–807.